An analysis of over 100,000 births in California showed such a wide variation in costs that the numbers can’t be explained by typical between-hospital variables.
An analysis of over 100,000 births in California showed such a wide variation in costs that the numbers can’t be explained by typical between-hospital variables. Published in BMJ Open, the report is a dramatic illustration of why health care is so expensive in the United States.
Researchers from the University of California, San Francisco, analyzed nearly 80,000 uncomplicated vaginal deliveries (DRG 775) and nearly 33,000 uncomplicated cesarean sections (DRG 766) performed in California in 2011. The data were from the California Office of Statewide Health Planning and Development and represented only privately insured patients.
After adjustment for patient demographics and clinical characteristics, they found that the charge for a vaginal delivery ranged from a low of $3,296 to as much as $37,227 and for a cesarean section from $8,312 to $70,908, depending on the hospital. Significantly lower charges were found at hospitals with middling competition, whereas higher adjusted charges were at hospitals with higher wages and casemixes and for-profits. Higher uninsurance rates were associated with significantly lower charges for cesarean section. Only 35% to 36% of between-hospital variation in charges could be explained by institutional and market-level factors.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More